Skip to main content
Clinical Trials/NCT03162185
NCT03162185
Unknown
Phase 4

The Effects of Serotonergic Challenge on Motor Learning and Neuroplasticity

Max Planck Institute for Human Cognitive and Brain Sciences1 site in 1 country60 target enrollmentApril 1, 2017

Overview

Phase
Phase 4
Intervention
Placebo
Conditions
Healthy Controls
Sponsor
Max Planck Institute for Human Cognitive and Brain Sciences
Enrollment
60
Locations
1
Primary Endpoint
Pinch Force Task.
Last Updated
8 years ago

Overview

Brief Summary

With this study, the investigators aim to test whether acute administration of selective serotonin reuptake inhibitors (SSRI) improves motor performance in a sequential motor learning task in comparison to placebo in healthy humans.

Detailed Description

Microdialysis findings in animal models provide evidence for a monoaminergic augmentation of motor function. However, this evidence is largely limited to noradrenaline and dopamine, with little evidence to support a similar effect for serotonin. What remains to be tested therefore, is whether acute serotonergic administration induces neural or behavioral changes during motor learning also. Using a sample of 60 female participants (with the possible inclusion of male participants at a later date), the investigators aim to test the effects of a serotonergic challenge on motor learning and plasticity in healthy participants.

Registry
clinicaltrials.gov
Start Date
April 1, 2017
End Date
November 30, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Max Planck Institute for Human Cognitive and Brain Sciences
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • right-handed
  • has taken oral contraceptives (ovulation inhibitor) continuously for at least 3 months
  • has read and agreed to study parameters

Exclusion Criteria

  • tattoos on head or neck
  • non-removable metal on or in body
  • alcohol abuse
  • is currently taking medication
  • smokes more than 3 cigarettes per day
  • positive drug test
  • pregnancy
  • plays an instrument professionally
  • plays videogames more than 2 hours per week
  • is a professional athlete

Arms & Interventions

Control group

Half of the participants ( n= 30) will receive the placebo.

Intervention: Placebo

Interventional group

Half of the participants (n = 30) will receive 20mg of the SSRI Escitalopram.

Intervention: Escitalopram

Outcomes

Primary Outcomes

Pinch Force Task.

Time Frame: 1 week

The primary outcome measure will be reaction time and accuracy of motor responses, as measured by the Pinch Force Task. This will be applied to both the experimental (SSRI) and control (Placebo) groups.

Study Sites (1)

Loading locations...

Similar Trials